MESO

Mesoblast Limited American Depositary Shares (MESO)

About Mesoblast Limited American Depositary Shares (MESO)

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Details

Daily high

$10.18

Daily low

$9.35

Price at open

$10.01

52 Week High

$11.05

52 Week Low

$1.61

Market cap

1.1B

Dividend yield

0.00%

Volume

142,637

Avg. volume

208,231

P/E ratio

-11.17

Mesoblast Limited American Depositary Shares News